Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia
✍ Scribed by S.M. Moon; H. Sung; M.-N. Kim; S.-O. Lee; S.-H. Choi; Y.S. Kim; J.H. Woo; S.-H. Kim
- Book ID
- 115100303
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 83 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1398-2273
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract After bone marrow (BM) or solid‐organ (SO) transplantation viremic __Cytomegalovirus__ (CMV) infection is observed frequently. Quantitative assay of CMV in blood helps the management of this clinical condition. In the present report, 83 samples from 39 solid organ recipients, three CMV
## Abstract Reconstitution of human cytomegalovirus (HCMV) T‐cell immunity is crucial in hematopoietic stem cell transplant (HSCT) recipients. The QuantiFERON®‐CMV assay for cellular HCMV‐specific immunity was evaluated in allogeneic HSCT recipients (n = 43) and patients with hematological malignan
## Abstract Immune mechanisms involved in control of cytomegalovirus (CMV) infection in the allogeneic stem cell transplantation setting have not been fully disclosed. CMV pp65 and IE‐1‐specific CD8^+^ T cells expressing IFN‐γ, TNF‐α, and CD107a, alone or in combination, and NKG2C^+^ NK cells were
## Abstract Transplantation Centers using human cytomegalovirus (HCMV) antigenemia‐based preemptive therapy will need to replace in the near future the antigenemia assay with a more standardized and automatable assay, such as a molecular assay quantifying HCMV DNA in blood (DNAemia). Thus, in view